FDA Investigator Anissa M Cheung

Anissa M Cheung has conducted inspections on 23 sites in 10 countries as of 07 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
23
Last Inspection Date:
07 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
Canada, United States of America, Japan, United Kingdom of Great Britain and Northern Ireland, Belgium, France, India, Germany, Denmark, Australia
FDA Investigators that have inspected at least one site in common with Anissa M Cheung:
Aimee Cunningham, PhD, Alla Kachko, PhD, Amy Devlin, PhD, Anastasia I Offordile, Angela K Shen, Anita R Michael, Ann L Demarco, Ann Marie Montemurro, Ann Marie Schofield, Anthony C Warchut, Anthony F Lorenzo, Arie C Menachem, Arthur S Williams, Jr, Audrey Thereset Uy, Ben A Firschein, Bharat Khurana, Brenda P King, Brentley S Collins, Brian S Keefer, Burnell M Henry, Carla J Lundi, Cassandra Overking, Catherine J Laufmann, CDR Cecily Jones, CDR Jeremy L Wally, PhD, Chad R Burger, Chao Ming Tsai, Christian D Lynch (CDL), Christina Capacci Daniel, PhD, Christina J Sauder, PhD, Christopher Downey, PhD, Christopher J Adams, Claire M Minden, Craig D Zagata, Cynthia Jim, CSO, Cynthia L Kelley, Daniel J Roberts, Dave Hafner, David J Hafner, David S Cho, PhD, Dawn M Braswell, Deborah M Trout, Debra J Bennett, Debra L Pagano, Destry M Sillivan, Dino A Fiegelstock, Dmitriy V Volokhov, PhD, Dr. Gang Wang, PhD, Dr. Willie F Vann, PhD, Dr. Zhihao Qiu (Peter), PhD, Edwin Melendez, Eileen A Liu, Ekaterina Allen, Ellen Huang, Ellen P Madigan, Erin C Hill, Felix Maldonado, Gene D Arcy, Gerald B Seaborn, Jr, Gunther Boekhoudt, PhD, Hala L Selby, Haruhiko Murata, Hector A Carrero, Helen B Ricalde, J David Doleski, Jacqueline Mdiaz Albertini, James C Maclaughlin, James M Mason, James R Evans, Jean Lhu Primmer, Jee Chung, PhD, Joan A Loreng, Joan Adamo, Joanne M Hajoway, John D Finkbohner, PhD, John F Cipollo, John M Mcinnis, John M Mclnnis, Jonathan Mclnnis, Joseph George, Joyce A Rockwell, Julianne C Mccullough, Julie D Bringger, Junho Pak, Justin A Boyd, Justine M Corson, Kara A Scheibner, PhD, Karyn M Campbell, Kathleen B Mihalik, Kathleen R Jones, PhD, Kathryn Carbone, MD, Katie Harris, Kelly N Kerr, Kelly R Lewis, Kenneth M Gordon, Kevin A Gonzalez, Kevin P Foley, Kirsten L Vadheim, PhD, Kristen D Evans, Larry K Austin, Laura Fontan, MS, Laurel A Beer, Laurie P Norwood, LCDR Debra Emerson, LCDR Margaret Edi Gennaro, Leslie D Wagner, Lewis K Antwi, Linda R Kuchenthal, Linda Thai, Lisa M Bellows, Lisa M Feola, Lisa M Parsons, Lori A Carr, LT John M Mastalski, Margarita Santiago, Marian E Major, PhD, Marian Majors, PhD, Marion Michaelis, Mark A Elengold, Martha T Olone, Maryna C Eichelberger, PhD, Maxwell Van Tassell, PhD, Megan A Haggerty, Michael Curbarg, Michael Gurbarg, Michael J Vardon, Michael Merchlinsky, Michele L Forster, PhD, Michelle M Noe Varga, Mihaly S Ligmond, Mohammad Heidaran, PhD, Monique C Lo, Mra Munizn, Nailing Zhang, Nancy T Waites, Nawab A Siddiqui, Nicholas Obiri, PhD, Obinna R Echeozo, Ogechi C Nna, Omotunde O Osunsanmi, Pankaj H Amin, Patricia D Stahnke, Paul W Keller, Paula A Trost, Penny H Mccarver, Pote Amin, Prabhu P Raju, Priscilla M Pastrana, Qiao Y Bobo, Rajiv R Srivastava, Ramon E Martinez, Randa Melhem, PhD, Rebecca K Olin, Richard H Penta, Richard W Thornton, Robert B Shibuya, MD, Robert D Tollefsen, Robert J Martin, Robert Jennings, Robin Levis, PhD, Roger F Zabinski, Rose Ashley, Satheesh Thomas, Scott E Norris, Sean R Marcsisin, Seth A Mailhot, Sharon K Thoma, PharmD, Sheila Dreher Lesnick, Shuang Tang, Sidney B Priesmeyer, Simone E Pitts, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Steven A Rubin, Susan F Laska, MS, Susan M Jackson, Susan T Hadman, Susan Yu, Swati Verma, Tammy L Chavis, Thai D Truong, Tina S Roecklein, Travis S Bradley, Unnee Ranjan, Victor J Gangi, Viviana Matta, Viviana R Ramirez, Vlada Matusovsky, Walter N Lange, Wayne E Seifert, Wei Wang, PhD, Xianghong Jing (Emily), PhD, Xiao Wang, Yanming An, PhD, Zhiping Ye, PhD, Zhong Li, PhD, Zhongren Wu

Anissa M Cheung's Documents

Publish Date Document Type Title
June, 2016 FDA 483 Protein Sciences Corporation - Form 483, 2016-06-15
September, 2017 FDA 483 Sanofi Pasteur - Form 483, 2017-09-27
June, 2015 FDA 483 ID Biomedical Corporation of Quebec - Form 483, 2015-06-05
September, 2019 EIR Merck Sharp & Dohme LLC - EIR, 2019-09-20
November, 2010 FDA 483 MedImmune Vaccines, Inc - Form 483, 2010-11-05
March, 2013 FDA 483 MEDIMMUNE U.K. LIMITED - Form 483, 2013-03-28
March, 2013 FDA 483 Seqirus Vaccines Limited - Form 483, 2013-03-19
March, 2012 FDA 483 GSK Vaccines GmbH - Form 483, 2012-03-27
June, 2014 FDA 483 Seqirus Pty Ltd - Form 483, 2014-06-13
September, 2019 FDA 483 Response Merck Sharp & Dohme LLC - Form 483R, 2019-10-07
March, 2011 FDA 483 Seqirus Vaccines Limited - Form 483, 2011-03-18
September, 2019 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2019-09-20
January, 2017 FDA 483 GlaxoSmithKline Biologicals SA - Form 483, 2017-01-27
July, 2021 EIR Pfizer Manufacturing Belgium NV - EIR, 2021-08-19
July, 2021 FDA 483 Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC - Form 483, 2021-07-23
June, 2011 FDA 483 SmithKline Beecham Pharma GmbH & Co. KG (dba GlaxoSmithKline Biologicals) - Form 483, 2011-06-22
July, 2018 FDA 483 Seqirus Pty Ltd - Form 483, 2018-07-17
February, 2014 FDA 483 Seqirus Inc - Form 483, 2014-02-12
March, 2023 FDA 483 UNIGEN INC. - Form 483, 2023-03-09
July, 2024 FDA 483 SERUM INSTITUTE OF INDIA PRIVATE LIMITED - Form 483, 2024-07-02
March, 2024 FDA 483 MEDIMMUNE U.K. LIMITED - Form 483, 2024-03-15

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more